Insider Selling: Outset Medical, Inc. (NASDAQ:OM) General Counsel Sells 32,930 Shares of Stock

Outset Medical, Inc. (NASDAQ:OM) General Counsel John L. Brottem sold 32,930 shares of the firm’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $0.80, for a total value of $26,344.00. Following the transaction, the general counsel now owns 181,188 shares in the company, valued at approximately $144,950.40. This trade represents a 15.38 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Outset Medical Price Performance

Shares of OM opened at $0.85 on Friday. The company has a current ratio of 6.49, a quick ratio of 5.04 and a debt-to-equity ratio of 4.12. The stock has a 50 day simple moving average of $1.01 and a 200 day simple moving average of $1.26. Outset Medical, Inc. has a 52-week low of $0.44 and a 52-week high of $5.22.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reissued a “sector perform” rating and set a $3.00 price target on shares of Outset Medical in a research report on Tuesday, January 7th.

Institutional Investors Weigh In On Outset Medical

A number of hedge funds and other institutional investors have recently made changes to their positions in OM. Huntington National Bank raised its holdings in shares of Outset Medical by 46.2% in the third quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after purchasing an additional 20,000 shares during the last quarter. Point72 Asset Management L.P. bought a new position in Outset Medical in the second quarter valued at $827,000. Squarepoint Ops LLC increased its stake in Outset Medical by 74.1% in the 2nd quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock valued at $309,000 after buying an additional 34,187 shares during the last quarter. National Bank of Canada FI boosted its stake in shares of Outset Medical by 79.2% during the 3rd quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock worth $35,000 after buying an additional 23,164 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Outset Medical in the 2nd quarter valued at about $259,000.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.